Abstract: Pharmacologically active, easy-to-deploy, biomechanically compatible, inflatable endovascular, drug-eluting stent are formed of a primary expandable polymeric or metallic construct, intimately mantled with a biomechanically compatible, polymeric microporous, microfibrous, compliant, stretchable fabric formed by direct electrospinning onto the outside surface of the primary construct using at least one polymer solution containing at least one active compound, selected from those expected to control key biological events leading to in-stent restenosis.

Abstract: The present invention is directed to lanthanide vanadate crystals having the formula LnVO4, wherein Ln is selected from La, Nd, Ce, Pr, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y, and combinations of at least two thereof, made by a hydrothermal method for a wide variety of end-use applications. The present method requires reacting a source of Ln3+ ions and a source of VO43+ ions, wherein Ln is selected from the group consisting of La, Nd, Ce, Pr, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y and combinations of at least two thereof, in an aqueous solution at a temperature of from about 350° C. to about 600° C. and at a pressure of from about 8 kpsi to about 40 kpsi, the aqueous solution comprising hydroxide ions at a concentration of from about 0.01 to about 5 molarity. Specifically, when made by the present hydrothermal method, single crystals of sufficient size for use in a variety of optical applications are readily formed.